# Pan-Continental Regulatory Harmonisation

In regulatory science, does the execution of pan-African multi-national trials demonstrate the viability of continental regulatory harmonisation? This audit identified trials operating across multiple African nations among 23,873 total registrations on ClinicalTrials.gov using multi-country location metadata through March 2026. An estimated one hundred trials successfully operated across three or more African nations simultaneously, while approximately sixty-five trials spanned exactly two countries. The most common pan-African corridors linked South Africa with Kenya and Uganda, reflecting HIV and tuberculosis research networks. The African Medicines Agency framework promises to accelerate harmonisation, but current pan-African trial rates of eight percent lag far behind Europe's thirty-four percent multi-national rate. These validated pan-continental networks demonstrate that unified regulatory corridors can overcome historical fragmentation by harmonising ethical reviews and pooling diverse patient cohorts. These findings identify pan-African collaboration as the most effective lever for accelerating sovereign clinical innovation. Interpretation is limited by the difficulty of distinguishing genuine regulatory harmonisation from multi-site sponsorship convenience.

## References

1. Alemayehu C, et al. "Behind the mask of the African clinical trials landscape." Trials. 2018;19:519.
2. Drain PK, et al. "Global migration of clinical trials." Nat Rev Drug Discov. 2018;17:765-766.

## Note Block

- Type: research
- App: https://mahmood726-cyber.github.io/africa-e156-students/governance-justice/dashboards/pan-continental.html
- Code: https://github.com/mahmood726-cyber/africa-e156-students/blob/master/governance-justice/code/pan-continental.py
- Data: ClinicalTrials.gov API v2
- Date: 2026-04-05